Metrochem API Private Limited
APIs USDMF / CEP Numbers Submission Date Status Written Confirmation
Acotiamide
Alogliptin Benzoate
Antazoline HCL CEP 2020-060 10 February,2020
Antazoline Phosphate USDMF 34330 1 January,2020
Apixaban USDMF 35518 30 December,2020
Apremilast
Azilsartan
Baloxavir Marboxil Product Under Validation
Bempedoic Acid
Bepotastine Besilate
Bilastine
Canagliflozin
Cenobamate
Cinitapride
Clopidogrel Bisulfate Form I USDMF 34334 5 February,2020 Indian CDSCO WC-0493
Clopidogrel Bisulfate Form II USDMF 34334 5 February,2020 Indian CDSCO WC-0493
Crisaborole
Dabigatran
Dapaglifloin Amorphous
Dapagliflozin
Dexketoprofen Trometamol USDMF 34732 21 March,2020 Indian CDSCO WC-0493
Dexlansoprazole USDMF 34971 29 September,2020
Dexrabeprazole
Dimethindene Maleate CEP 2021-080 6 February,2021
Edoxaban
Efinaconazole
Elagolix
Elobixibat Product Under Validation
Eltrombopag
Empagliflozin USDMF 35345 31 October,2020 Indian CDSCO WC-0493
Empagliflozin Amorphous
Ertugliflozin
Esomeprazole Magnesium Dihydrate USDMF 35519 ; CEP 2021-022 29 December,2020 ; 28 December 2020
Note: None of the products will be supplied to the countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purpose only. However, the final responsibility exclusively lies with the buyer. Metrochem API Private Limited
APIs USDMF / CEP Numbers Submission Date Status Written Confirmation
Esomeprazole Magnesium Trihydrate USDMF 35400 ; CEP 2020-386 28 November,2020 ; 21 November,2020
Esomeprazole Sodium CEP 2020-214 30 June,2020
Etoricoxib USDMF 34537 22 February,2020 Indian CDSCO WC-0493
Febuxostat USDMF 35578 13 February,2021
Febuxostat Form A USDMF 35797 27 March,2021
Fingolimod
Fosravuconazole Product Under Validation
Gabapentin
Garenoxacin
Ilaprazole
Imeglimin Hydrochloride
Ipragliflozin
Isavuconazonium Sulphate
Itraconazole Indian CDSCO WC-0493
Ivabradine Product Under Validation
Lacosamide
Lansoprazole USDMF 35485 ; CEP 2021-009 22 December,2020 ; 25 December,2020
Lasmiditan
Levocetirizine Di Hcl USDMF 34731 12 May,2020 Indian CDSCO WC-0493
Levomilnacipran
Loxoprofen Sodium Product Under Validation
Lurasidone Hcl USDMF 34756 14 July,2020
Migalastat
Mirabegron
Mirabegron Amorphous
Montelukast Sodium
Omecamtiv Marcabil Product Under Validation
Omeprazole USDMF 34759 ; CEP 2020-182 3 June,2020 ; 8 June,2020 Indian CDSCO WC-0493
Omeprazole Magnesium USDMF 35390 ; CEP 2020-380 20 November,2020 ; 12 November,2020
Omeprazole Sodium CEP 2020-372 10 November,2020
Oseltamavir Phosphate
Oxcarbazepine
Oxiconazole Nitrate USDMF 34173 23 September,2019 Indian CDSCO WC-0493
Note: None of the products will be supplied to the countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purpose only. However, the final responsibility exclusively lies with the buyer. Metrochem API Private Limited
APIs USDMF / CEP Numbers Submission Date Status Written Confirmation
Ozenoxacin USDMF 35487 26 December,2020
Pantoprazole Magnesium USDMF 35516 25 March,2021
Pantoprazole Sodium Sesquihydrate USDMF 35577 31 March,2021
Pirfenidone
Ponesimod
Posaconazole USDMF 35517 11 January,2021
Prucalopride Succinate USDMF 34970 21 August,2020
Rabeprazole Sodium USDMF 35344 27 November,2020
Ranolazine
Relugolix
Remogliflozin
Saxagliptin
Silodosin USDMF 34538 3 March,2020 Indian CDSCO WC-0493
Silodosin Beta Form
Siponimod
S-Pantoprazole
Stiripentol Product Under Validation
Tafenoquine Succinate Product Under Validation
Tedizolid Phosphate USDMF 35515 20 February,2021
Teneligliptin USDMF 35576 26 March,2021
Ticagrelor
Tofacitinib
Topiroxostat
Tranexamic Acid Product Under Validation
Trelagliptin
Upadacitinib Tartrate Product Under Validation
Vibegron
Vigabatrin
Vilanterol
Vildagliptin
Vonoprazan Fumarate USDMF 35150 31 August,2020
Vortioxetine Product Under Validation
Note: None of the products will be supplied to the countries in which this could be in conflict with existing patents. Further, any products under patent will be offered for R&D purpose only. However, the final responsibility exclusively lies with the buyer.